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Abstract 
Episodes of physical exertion are associated with an immediately higher risk of 
cardiovascular events while physical activity over the long-term is cardioprotective. To 
assess the transient and long-term risk of ventricular arrhythmia (VA), we conducted a nested 
case-crossover study within a prospective cohort of 97 patients with implantable 
cardioverter-defibrillators (ICD). Within an hour of episodes of exertion, the risk of VA was 
5.3 (95% CI 2.7 – 10.6) times greater compared to periods of rest. The association was higher 
among patients with aerobic fitness below the median (RR[relative risk]=17.5, 95% 5.2 – 
58.5) than for patients with aerobic fitness above the median (RR=1.2, 95% CI 0.4 – 4.2, p-
homogeneity = 0.002) and higher among patients who were sedentary (RR=52.8, 95% 10.1 – 
277) compared to individuals who were not (RR=3.2, 95% 1.3 – 7.6, p-
homogeneity=0.0002). We found no statistically significant difference in time-to-VA by 
aerobic fitness or sedentary behaviour. In this clinical cohort, there is an elevated risk of VA 
within an hour of exertion, particularly in patients with low aerobic fitness and sedentary 
behaviour. 
Keywords 
Case-crossover, ventricular arrhythmia, implantable cardioverter-defibrillator, exertion, 
sedentary 
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Chapter 1  
1 Introduction 
A ventricular arrhythmia is an abnormal heart rhythm that may prevent the ventricles of the 
heart from contracting in coordination with each other1. Ventricular tachycardia and 
ventricular fibrillation are two types of arrhythmia that may result in sudden cardiac death if 
they are not treated immediately. Patients at risk of fatal arrhythmia can be eligible to receive 
an implantable cardioverter-defibrillator (ICD), which can detect arrhythmia and deliver an 
electric discharge to correct abnormal rhythm. The ICD stores information on each episode 
of arrhythmia in its memory, which can then be analyzed as objective precisely timed 
assessments of ventricular arrhythmia.  
During and shortly after an episode of physical exertion itself, there is a transiently elevated 
risk of myocardial infarction, stroke, and ventricular arrhythmia among individuals who are 
at high risk for these events2. Over the long term however, engaging in physical exertion is 
associated with a reduction in the baseline risk of cardiovascular events in both men and 
women. In this thesis, we explore these opposing roles of physical exertion in ventricular 
arrhythmia. We begin with a literature review where we describe the mechanisms of 
ventricular arrhythmia, along with a summary of its epidemiology, its treatment by 
implantable cardioverter-defibrillator (ICD), and its relationship with exertion. We outline 
objectives and hypotheses in Chapter 3 and detail study design and data collection in Chapter 
4. In Chapter 5, we measure the immediate risk of ventricular arrhythmia following physical 
exertion. In Chapter 6, we assess the long-term risk of ventricular arrhythmia by aerobic 
fitness and sedentary behaviour.  The final chapter discusses both studies in terms of their 
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contributions to the body of knowledge, their methodological strengths and limitations, and 
the implications for future research. 
 
1.1 References 
1. Cranefield PF, Wit AL, Hoffman BF. Genesis of cardiac arrhythmias. Circulation. 
1973;47(1):190-204. 
2. Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with 
triggering of acute cardiac events: systematic review and meta-analysis. JAMA. 
2011;305(12):1225-1233. 
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Chapter 2  
2 Literature review 
2.1 Mechanisms of ventricular arrhythmia 
An arrhythmia or irregular heartbeat is characterized by abnormal electrical activity in the 
cardiac muscle, which may disrupt the mechanical function of the heart. Waves of 
depolarization cause contractions in the heart muscle. An arrhythmia can impair normal 
contraction by dysfunctional impulse formation, abnormal impulse frequency, or both. 
Arrhythmia occurs through three principle mechanisms called reentry, enhanced 
automaticity, and triggered activity, and patients with damaged myocardium from 
cardiovascular disease are at an increased risk of ventricular arrhythmia from each of 
these mechanisms1. Scar tissue is created from prior myocardial infarction or generalized 
scarring from dilated cardiomyopathy and other cardiomyopathic processes. Islands of 
scar tissue in the myocardium increase the risk of arrhythmia through reentrant circuits. 
Tachycardia or rapid heartbeat can initiate due to an extrasystolic beat blocked in one 
direction around the scar and conducting in another2,3. These extrasystolic beats are more 
common in patients with poor ventricular function, especially during exercise4-8. In 
enhanced automaticity, arrhythmia is caused by an increase in the rate of phase 4 
depolarizations of cardiac cells which increase impulse frequency. This regulation is 
under the direct influence of autonomic activity, which is considerably abnormal in 
patients with ventricular dysfunction9,10. Triggered activity is another mechanism of 
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arrhythmia and is caused by delayed afterdepolarizations creating multiple abnormally 
initiated waves of depolarization. 
2.2 Epidemiology of ventricular arrhythmia 
Each year, approximately 40 000 Canadians die from cardiac disease11. Approximately 
one half of these happen suddenly and are mostly due to ventricular tachycardia and 
ventricular fibrillation. A similar trend is observed worldwide; half of cardiac deaths 
across the globe occur suddenly, 80% of which are attributed to ventricular arrhythmia12. 
The risk of ventricular arrhythmia is higher in individuals who are older, male, and have 
lower ejection fraction13 – a measure of cardiac dysfunction. The risk of ventricular 
arrhythmia also varies across lifestyle and socio-demographic characteristics. Notably, 
the decreasing trend in sudden death due to cardiac cause from 1950 to 1999 was largely 
attributed to advances in its treatment and prevention14.  
2.3 Implantable cardioverter-defibrillator (ICD) 
Patients at risk of ventricular arrhythmia are eligible to receive an implantable 
cardioverter-defibrillator (ICD), a device that is implanted in the upper chest. Rapid 
ventricular rates above a programmed threshold may indicate ventricular tachycardia or 
ventricular fibrillation and are treated by anti-tachycardia pacing (ATP) or shock therapy. 
Sensed events are recorded and assessed between different bipoles and allow for near-
field recorded ventricular electrograms which detect arrhythmias, and far-field recorded 
electograms which assess atrial activity. With a review of both these recordings, an 
electrophysiologist may determine whether the arrhythmia originated in the ventricles 
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and if ICD therapy is appropriate`. While the ICD detects and treats arrhythmia, it does 
not by itself alter the risk of subsequent episodes of ventricular arrhythmia. 
2.4 ICD implantation wait times 
The majority of patients receive an ICD under the category of “primary prevention” 11, 
indicating that they are identified as high risk for ventricular arrhythmia based on a poor 
ejection fraction and do not have a history of cardiac arrest15. After ICD implant, these 
patients may have a 25% relative risk reduction and 8% absolute risk reduction in all-
cause mortality over 2 to 4 years compared to treatment by anti-arrhythmic medication15. 
Patients receiving ICD for primary prevention are considered ‘Priority Class 2’ by the 
Cardiac Care Network of Ontario and are assigned a target wait time of 56 days for 
implant. The London Health Sciences Centre is one of nine ICD implanting sites in 
Ontario and it has a median wait time of 36 days, with a mean of 27 patients waiting. The 
median wait time among all nine sites in Ontario from January-March 2008 was 30 days 
(range of 5-59 days) with an average of 164 patients awaiting ICD implant16. Current 
recommendations do not directly address the issue of patient activity level during wait for 
ICD implant17-19, a period where patients are unprotected against possibly fatal 
ventricular arrhythmia.  
2.5 Physical exertion triggering ventricular arrhythmia 
Among individuals with appropriate substrate, the mechanisms of ventricular arrhythmia 
can be potentiated by transient changes in autonomic tone, circulating catecholamines, 
electrolyte levels, oxygen desaturation, and pH balance – all of which occur during an 
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episode of physical exertion2. While the precise link between a stress and ventricular 
arrhythmia is uncertain, there is evidence that population triggers like earthquakes and 
war and individual triggers like emotional and physical stress may precipitate ventricular 
arrhythmia among those who are predisposed20. The association between episodes of 
physical exertion and ventricular arrhythmias have been documented in anecdotal reports, 
in observational case-crossover studies, and in experimental studies using exercise stress 
testing which incrementally increase the difficulty of exertion while concurrently 
monitoring heart rhythm21,22. There have been two prior studies in patients with ICD 
which have reported a higher risk of ventricular arrhythmia immediately following 
physical exertion23,24, but no study has examined if the heightened relative risk of 
ventricular arrhythmia following an episode of exertion varies by level of aerobic fitness 
or by sedentary behaviour.  
2.6 Habitual physical exertion protecting against ventricular 
arrhythmia 
Safe levels of habitual physical exertion are widely encouraged in older adults, even 
among those who have several comorbidities, low levels of fitness, or functional 
limitations preventing specific movements and activities25. Habitual physical exertion 
reduces the risk of cardiovascular disease, coronary heart disease, hypertension, stroke, 
and can serve as effective therapy for many chronic conditions26. Similarly, sedentary 
behaviour is associated with a higher baseline risk of cardiovascular events25. This 
relationship may also exist between habitual physical exertion and ventricular 
arrhythmia; exertion over the long term may protect against arrhythmia by reducing 
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adrenergic activation and increasing vagal tone2. After a monitored exercise training 
program, patients with ICD saw improvements in quality of life and peak aerobic 
capacity, an indicator of aerobic fitness27. Further, higher levels of fitness28, a byproduct 
of regular activity, and higher levels of habitual physical exertion29,30 are associated with 
a reduced risk of ventricular arrhythmia in patients with ICD. Habitual physical exertion 
may confer a protective advantage against ventricular arrhythmia, similar to its well-
studied benefits for other chronic and acute cardiovascular illnesses.   
There is evidence that physical exertion can act as both a risk factor and a protective 
factor for ventricular arrhythmia, the former in the form of transiently elevated short term 
risk and the latter in the form of long-term baseline risk reduction31. It is also possible 
that the elevated short-term risk is lower in those who have higher levels of physical 
fitness as a result of their habitual physical exertion. These different associations of the 
outcome to the exposure across time, together with the possibility that the exposure is 
also an effect modifier, pose special methodological challenges to estimating these 
associations using epidemiological methods. Partially in response to these 
methodological challenges, groups of interventional cardiologists have been enrolling 
patients into prospective cohorts designed to conduct case-crossover analysis.  In the next 
chapter we briefly describe the origins of a prospectively enrolled cohort of patients who 
underwent ICD implantation at the London Health Sciences Centre.    
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Chapter 3  
3 Study methods 
3.1 MOVE-IT: Monitoring Of Ventricular rhythm & Exercise 
– ICD sTudy 
MOVE-IT was a single-centre prospective cohort study of 97 consecutive patients 
recruited from May 2009 to July 2012 in the London Health Sciences Centre in London, 
Ontario, Canada. The study protocol was approved by the Health Sciences Research 
Ethics Board (REB) and all participants provided informed consent. MOVE-IT was 
funded by the Heart and Stroke Foundation of Ontario to assess the short- and long-term 
risk of ventricular arrhythmia associated with physical exertion among patients with ICD. 
3.1.1 Patient recruitment 
All patients who received ICD implant in the London Health Sciences Centre in this 
period were considered for study enrolment. The decision to offer ICD was determined 
by consensus from a team of four cardiac electrophysiologists using evidence-based 
guidelines. Guidelines for primary prevention ICD implant are set by Canadian Heart 
Rhythm Society criteria as follows: 
- Ischemic Heart Disease and 
o Post-MI > 1 month 
o Post coronary bypass > 3 months 
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o Ejection Fraction < 30% 
o Appropriate medical therapy 
o No contraindications 
- Non-Ischemic Heart Disease and 
o Ejection Fraction < 30% 
o NYHA class II/III 
o Appropriate medical therapy 
o Sufficient time since diagnosis (recommended 9 months) to exclude acute 
myocarditis or other transient causes of ventricular dysfunction 
o No contraindications 
Participants were categorized as “secondary prevention” patients if they had a prior 
cardiac arrest without reversible cause, or sustained ventricular tachycardia with an 
ejection fraction less than 40%.  
Patients were excluded from the study if they met any of the following criteria: 
o Under 18 years of age 
o Symptoms of angina with any of the following features: new onset; CCS class III 
or IV pending assessment; plan for revascularization 
o Comorbid non-cardiac condition associated with anticipated survival less than 2 
years 
o Physical limitations precluding moderate exercise 
o Participation in a concomitant research study that would conflict or affect 
outcome of this study 
o Unwilling or unable to provide consent 
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3.1.2 Study schedule 
Patients underwent implantation of Medtronic, Guidant, or St. Jude ICD where the 
number of leads (ventricular +/- atrial) was determined by clinical scenario according to a 
team of electrophysiologists and the implanting physician. Patients returned for device 
interrogation 2 weeks after implant and every 6 months thereafter, in accordance with 
standard clinical practice. Study visits were timed to coincide with this clinical schedule; 
at the initial study visit, patients completed a structured medical questionnaire (appendix 
A) and underwent cardiopulmonary exercise stress testing to measure aerobic fitness. 
Patients who experienced symptomatic ventricular arrhythmia completed a post-therapy 
questionnaire (appendix B) administered over phone or at clinic visit by research nurse 
within 72 hours of device discharge. Electrograms for any recorded events were collected 
during device interrogation at scheduled study visits.  
3.1.3 Sample size 
Calculations for cohort size were based on the analysis planned to assess long-term risk 
of ventricular arrhythmia because it was expected to require the larger sample size. Pilot 
data indicated that ventricular arrhythmia occurred in approximately 20% of ICD patients 
per year, which is consistent with published data1. It was estimated that patients below 
median aerobic fitness would have a 35% annual incidence of ventricular arrhythmia and 
patients above median aerobic fitness would have a 15% annual incidence, which results 
in an estimated hazard ratio of 0.55. With this ratio, to detect a difference in freedom-
from-ventricular arrhythmia using the Kaplan-Meier method with 80% power at a 2-sided 
alpha level of 0.05, 128 patients would be required2. With a conservative loss to follow 
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up of 10%, a total of 140 patients made the desired sample size. Ultimately, the achieved 
sample size was smaller than the desired size because recruitment and completion of 
cardiopulmonary stress testing was less than anticipated.  
3.2 References 
1. Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NA, 3rd, Link 
MS. Time-dependence of appropriate implantable defibrillator therapy in patients 
with ischemic cardiomyopathy. Journal of cardiovascular electrophysiology. 
2008;19:784-789. 
2. Freedman LS. Tables of the number of patients required in clinical trials using the 
logrank test. Statistics in medicine. 1982;1:121-129. 
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Chapter 4  
4 Objectives and hypotheses 
In Chapter 5, we explore the immediate risk of ventricular arrhythmia following episodes 
of physical exertion. In this clinical population, we hypothesized that the risk of 
ventricular arrhythmia is elevated within an hour of physical exertion compared to 
periods of rest and within an hour of vigorous physical exertion compared to other times. 
Our secondary analysis in Chapter 5 compares this immediate risk of ventricular 
arrhythmia following physical exertion between individuals with lower levels of aerobic 
fitness and individuals with relatively higher levels of aerobic fitness, and between 
individuals who are sedentary compared to individuals who are not sedentary. We 
hypothesized that there is a higher risk of ventricular arrhythmia following exertion 
among individuals with lower levels of fitness and among those who are sedentary.  
In Chapter 6, we explore time-to-ventricular arrhythmia over the study period and test if 
it differs by level of aerobic fitness or sedentary behaviour. We hypothesized that there is 
reduced time-to-arrhythmia among individuals with lower levels of aerobic fitness 
compared to those with higher levels of aerobic fitness, and that there is reduced time-to-
ventricular arrhythmia among those who are sedentary compared to those who are not 
sedentary.  
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Chapter 5  
5 Physical exertion and the immediate risk of ventricular 
arrhythmia1 
5.1 Introduction 
There is consistent evidence that discrete episodes of physical exertion are associated 
with a transiently elevated risk of cardiovascular events including myocardial infarction 
and stroke in high-risk clinical populations. A few studies have described this association 
in ventricular arrhythmia, but none have examined if this risk varies by level of aerobic 
fitness or sedentary behaviour.  
Although appropriate anti-tachycardia pacing (ATP) and shocks delivered by implantable 
cardioverter-defibrillators (ICD) may be life-saving, ICD therapy is associated with 
psychological distress and reduced quality of life1,2. Reducing sedentary behaviour is 
important for healthy aging in older adults3, but people with ICDs commonly report 
concerns that physical exertion will elicit a shock response so they may abstain from or 
engage in lower levels of physical activity to avoid shocks4. 
In this study, we evaluated whether there is a higher risk of ventricular arrhythmia during 
and shortly after episodes of physical exertion compared to rest. We hypothesized that 
                                                 
1
 A version of this paper is in press in the Canadian Journal of Cardiology 
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lower aerobic fitness, measured by peak VO2, and sedentary behaviour would be 
associated with a higher risk of ventricular arrhythmia following isolated bouts of 
physical exertion. 
5.2 Methods 
5.2.1 Study population 
The MOVE-IT study is a prospective cohort of 97 consecutive ICD patients recruited at 
the time of implant in the London Health Sciences Centre in London, Ontario, Canada 
from May 2008 to July 2012. Patients received primary and secondary prevention ICD 
implant based on criteria set by the Canadian Heart Rhythm Society5. Patients were 
ineligible for the study if they met any of the following criteria: < 18 years of age, 
comorbid non-cardiac condition associated with anticipated survival < 2 years, or 
physical limitations precluding moderate exercise. Thirty therapies among 22 patients 
treated symptomatic ventricular arrhythmia, which makes the cohort for analysis. 
5.2.2 Study design 
The case-crossover design was developed to study the transient effect of an intermittent 
exposure on events with acute onset6. Rather than comparing different exposure groups at 
the same time, the case-crossover design compares the same person at different times, 
using each person as their own control. As a result, there is no confounding by fixed (e.g. 
sex) or slowly varying characteristics. This requires collecting information on exposure 
(e.g. physical exertion) immediately preceding the outcome event (e.g. ventricular 
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arrhythmia) and comparing this with the expected frequency of exposure over a similar 
time period based on the study patient’s habitual pattern (appendix D). 
5.2.3 Physical exertion 
At the initial study visit, patients reported their average frequency and duration of light, 
moderate, and vigorous exertion activities over the last 6 months (appendix A) using the 
15-point (scores ranging from 6-20) visual analogue Borg scale7 (appendix C) to gauge 
exertion intensity. Patients who reported no moderate to vigorous exertion in the past 6 
months were classified as sedentary and patients who reported any moderate to vigorous 
exertion were deemed not sedentary. Information on timing of physical exertion and 
exposure to other possible behavioural precursors was also collected.  
Patients who experienced symptomatic ventricular arrhythmia completed a semi-
structured questionnaire within 72 hours of device therapy by telephone or at the clinic 
(appendix B). Patients reported the last time before device discharge that they had 
engaged in light, moderate, and vigorous exertion with the following response options: 
never, at the time of shock, 1/2 hour before, 1 hour before, 2 hours before, 3-6 hours 
before, 6-24 hours before, 1-2 days before, 3-4 days before, or ≥ 5 days before. In the 
questionnaire, patients also described the specific activity at the time of and immediately 
preceding ICD therapy, and their symptoms surrounding the event.  Information on 
sexual intercourse and other potential triggers was also collected from the questionnaire 
and information on age, medical history, and medications was abstracted from medical 
records.   
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5.2.4 Aerobic fitness 
A modified Bruce protocol8 was conducted 2 weeks after ICD implant to measure peak 
VO2. An initial 3 minute stage of 1.7 mph and 0% gradient (2.3 METs) was followed by 
3 minute stages as follows: 1.7 mph at 5% grade (3 METs), 1.7 mph at 10% grade (4.6 
METs), 2.5 mph and 12% grade (7 METs), 3.4 mph and 14% grade (10.2 METs), 4.2 
mph and 16% grade (13.5 METs), 5 mph and 18% grade (17.2 METs). Peak VO2 was 
measured continuously throughout the treadmill test using computerized online rapid gas 
analyzers for oxygen and carbon dioxide9 of the Vmax™ Encore Metabolic Cart 
(CareFusion, San Diego, CA). The treadmill test was performed adhering to accepted 
standards10, with continuous 12 lead ECG monitoring and recordings at rest prior to 
exercise, at least every 3 minutes during exercise, peak exercise, and at 1-minute intervals 
for 6 minutes during recovery. Symptoms of chest pain, leg fatigue, and dyspnea were 
quantified using the Borg Scale. The exercise test was terminated when the subject could 
not continue due to symptoms (such as fatigue, dyspnea or chest pain) or if it was deemed 
medically necessary due to any of the following clinical findings: > 2 mm of horizontal 
or downsloping ST segment depression; persistent ≥10 mm Hg decline in systolic blood 
pressure; a hypertensive (systolic blood pressure > 280 mm Hg, diastolic blood pressure 
> 120 mm Hg) blood pressure response; or the development of significant arrhythmias. 
Written informed consent was obtained from each patient prior to exercise testing. 
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5.2.5 ATP or shock 
Interrogation of the ICD provides a summary of detected arrhythmias; date, time, 
duration, therapies, and rhythm prior to onset are stored in the device memory. 
Electrograms were also available for each episode. The treating electrophysiologist and 
lead investigator (LJG) reviewed all stored electrograms to confirm included events.   
5.2.6 Statistical analysis 
In the case-crossover design, data are stratified on each individual event6,11. In each 
stratum, the patient’s exposure in the hour preceding an event (hazard period) is 
compared to their expected frequency of exposure in a random hour based on their usual 
exposure time. We multiplied the usual frequency of activity by the usual duration of 
activity to calculate annual exposure time and we subtracted this value from total hours in 
a year to calculate annual non-exposure time. Using methods for sparse data12, we 
calculated the Mantel-Haenszel incidence rate ratio (RR) for person-time and 95% 
confidence intervals comparing the observed exposure in the hazard period to the 
expected frequency of exposure. We evaluated whether this association was different 
between people above and below the median level of peak VO2 in this sample and 
between individuals who were and were not sedentary. We compared these subgroups 
using a Wald χ2 test of homogeneity12. Analyses were performed using macro in SAS 9.4 
(SAS Institute, Cary, NC). 
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5.3 Results 
A total of 30 events occurred among 22 patients (20 men, 2 women). Six (20%) were 
ventricular tachycardia, 12 (40%) were fast ventricular tachycardia, and 12 (40%) were 
ventricular fibrillation. Seven (23%) events were terminated by ATP alone, 12 (40%) by 
shock alone, and 11 (37%) by shock after ATP. The characteristics of the 22 patients who 
experienced symptomatic ventricular arrhythmia are presented in Table 5-1. The mean 
age of these study patients was 62.2 ± 7.6. The mean left ventricular ejection fraction was 
26.9%, ranging from 15-42%. Twelve patients (55%) had a history of myocardial 
infarction, 6 patients (27%) had diabetes mellitus, and 21 (96%) were on beta blocker 
medication. Fourteen (64%) patients received primary prevention ICD, and 8 (36%) 
received ICD for secondary prevention.  
Most ICD therapy (76%) occurred between 6AM and 6PM and an equal proportion of 
events occurred before and after 12:00PM (Figure 5-1). Sixteen (53%) therapies were 
delivered within an hour of physical exertion (14 light or moderate, 2 vigorous) and 13 
(43%) events occurred during the episode of physical exertion.  
The results of the case-crossover analyses are presented in Table 5-2. The risk of 
ventricular arrhythmia within an hour of any exertion was 5.3 (95% CI 2.7 – 10.6) times 
greater compared to periods of rest. The risk of ventricular arrhythmia was 23.3 (95% CI 
5.8 – 91.9) times greater within an hour of vigorous exertion compared to other times. 
The risk of ventricular arrhythmia within an hour of any exertion was higher among 
patients with lower levels of aerobic fitness (peak VO2 < 18.2 mL/kg/min) than for 
patients with higher levels of aerobic fitness (p-homogeneity=0.002). Similarly, this risk 
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was higher among habitually sedentary patients compared to patients who were not 
sedentary (p-homogeneity=0.0002). The results were not substantially different from 
sensitivity analyses that were restricted only to shock events. 
5.4 Discussion 
In this clinical population, there was a higher risk of confirmed ventricular arrhythmia 
within an hour of exertion compared to periods of rest. The association was stronger for 
patients below the median peak VO2 than for patients with peak VO2 above the median, 
suggesting that high aerobic fitness may lower the risk of ventricular arrhythmia 
following episodes of exertion. The association between an episode of exertion and 
ventricular arrhythmia was also stronger among those who were sedentary compared to 
those who were not sedentary. 
Our results are consistent with prior research on exertion as an acute trigger of ventricular 
arrhythmia. Lampert et al.13 and Fries et al.14 reported a higher risk of ICD therapy 
immediately following an episode of exertion compared to other times. Additionally, 
previous research has shown that the relative risk of myocardial infarction and sudden 
cardiac death following episodes of physical exertion is higher among people who are 
sedentary15-17. This is the first study to show that there is a higher risk of ventricular 
arrhythmia following episodes of physical exertion among those with lower levels of 
aerobic fitness and sedentary behaviour.  
Exercise confers numerous long-term benefits18, but isolated episodes of exertion are 
accompanied by transient changes that may induce ventricular arrhythmia among 
 25 
 
 
individuals with appropriate substrate19. Activation of the sympathetic nervous system 
from exertion leads to several mechanical, metabolic, and electrophysiological changes20. 
Increased heart rate, ionotropy, blood pressure, and afterload increase myocardial oxygen 
demand, that may lead to ischemia and in turn precipitate ventricular arrhythmia20. In 
addition, changes in electrolytes and pH may potentiate the risk of arrhythmia20. Elevated 
levels of circulating catecholamines increase myocardial conduction velocity and 
membrane refractoriness, that may increase susceptibility to ventricular arrhythmia20. 
Further, increased sympathetic activity increases calcium influx that may increase the 
amplitude of delayed afterpotentials, which can cause triggered automaticity and 
enhanced automaticity20. Also, vagally-mediated recovery is typically delayed in patients 
with low ejection fraction21, creating an elevated period of risk longer than the episode of 
exertion itself. The impact of these changes ultimately varies by individual 
characteristics; arrhythmic substrate may influence susceptibility to arrhythmia, but 
participation in habitual activity may protect against the brunt of each episode of 
exertion.  
5.4.1 Strengths and limitations 
By using each patient as his or her own control, the case-crossover design eliminates 
between-person confounding by all fixed and slow-varying characteristics – both 
measured and unmeasured. However, confounding by time of day is possible because 
ventricular arrhythmias are more likely to occur in the morning, when physical activity 
may also be more likely. However, the timing of both ventricular arrhythmias and 
physical activity among MOVE-IT patients were spread across the day. We prospectively 
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collected usual frequency and duration of physical exertion at the initial study visit so that 
occurrence of symptomatic ventricular arrhythmia could not influence a patient’s 
perspective on their physical activity habits. Further, in addition to assessing sedentary 
behaviour by self-report, we studied the impact of peak VO2, an objectively collected 
measure of aerobic fitness.  
All patients who reported activity at the time of therapy were also classified as active by 
the ICD’s activity sensor, which senses mechanical vibration using a single-axis 
accelerometer. However, several patients who reported being at rest during therapy were 
also classified as active by the ICD activity sensor. Although self-reported exertion at the 
time of ICD therapy may be over- or underreported by some patients, we used this 
measure because of concerns that the objectively recorded accelerometer data was too 
sensitive to small movements, does not measure exertion intensity, and only records 
activity at the time of device discharge. While this was a small study, we were still able 
to identify a statistically significant difference in the association between exertion and 
ventricular arrhythmia across levels of aerobic fitness and sedentary behaviour.   
5.4.2 Conclusion 
We found that there was a transiently elevated risk of ventricular arrhythmia within an 
hour of episodes of light, moderate, and vigorous exertion. Moreover, we found that this 
association as stronger among patients with lower levels of aerobic fitness and among 
patients with habitually sedentary behaviour.  
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Table 5-1.  Baseline characteristics for 22 MOVE-IT patients experiencing 
symptomatic ventricular arrhythmia, mean ± SD or n (%)  
 
 Full cohort° Aerobic fitness 
below median† 
Aerobic fitness 
above median 
 n=22 n=9 n=9 
Age (years) 62.2 ± 7.6 60.9 ± 10.2 63.3 ± 6.0 
Men 20 (91%) 7 (78%) 9 (100%) 
Ejection fraction (%)* 
(by MUGA scan) 
26.9 ± 7.3 
 
28.0 ± 12.5 
 
24.8 ± 5.3 
 
Blood pressure (mmHg) 
Systolic 
Diastolic 
 
116.6 ± 71.4 
71.4 ± 12.0 
 
105.9 ± 11.1 
65.7 ± 9.3 
 
115.6 ± 17.1 
73.9 ± 13.3 
Body mass index (kg/m2 ) 29.3 ± 4.9 30.2 ± 6.3 29.2 ± 3.9 
Peak VO2 (mL/kg/min) 18.73 ± 5.80 13.9 ± 2.8 23.5 ± 3.4 
Sedentary‡ 8 (37%) 5 (55%) 1 (11%) 
Indication for ICD    
Primary prevention 14 (64%) 7 (78%) 6 (67%) 
Secondary prevention 8 (36%) 2 (22%) 3 (33%) 
Cardiovascular history    
 Ischemic heart disease 12 (55%) 4 (44%) 5 (56%) 
 Prior revascularization 7 (32%) 2 (22%) 3 (33%) 
Myocardial infarction 
Non-Ischemic cardiomyopathy 
Congestive heart failure 
Valvular heart surgery 
Congenital heart surgery 
12 (55%) 
8 (36%) 
12 (55%) 
3 (14%) 
1 (5%) 
3 (33%) 
4 (44%) 
6 (67%) 
1 (11%) 
1 (11%) 
6 (67%) 
3 (33%) 
5 (56%) 
2 (22%) 
0 
Other Medical history    
 Diabetes mellitus 6 (27%) 3 (33%) 3 (33%) 
 Hypertension 
Hyperlipidemia 
12 (55%) 
6 (27%) 
5 (56%) 
3 (33%) 
5 (56%) 
2 (22%) 
Cardiac medication history    
 Beta blocker 21 (96%) 9 (100%) 8 (89%) 
 ACE inhibitors 
Angiotensin receptor blocker 
Diuretic 
Digoxin 
Calcium channel blocker 
Class 1 antiarrhythmic 
17 (77%) 
5 (23%) 
14 (64%) 
7 (32%) 
2 (9%) 
3 (14%) 
7 (78%) 
2 (22%) 
7 (78%) 
4 (44%) 
1 (11%) 
1 (11%) 
6 (67%) 
3 (33%) 
5 (56%) 
3 (33%) 
1 (11%) 
1 (11%) 
°4 patients did not complete cardiopulmonary exercise testing to determine peak VO2 
*4 patients did not have information on ejection fraction from MUGA scan  
†Median aerobic fitness (peak VO2) = 18.2 mL/kg/min 
‡Patients who reported no moderate to vigorous exertion in the past 6 months at initial 
assessment were classified as sedentary and patients who reported any moderate to vigorous 
exertion were deemed not sedentary 
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Table 5-2. Relative risk and 95% confidence intervals of symptomatic ventricular 
arrhythmia within 1 hour of exertion among 22 MOVE-IT patients 
 
 
Ventricular 
arrhythmia within 
1 hour of exertion 
Patients 
Relative risk 
(95% CI) 
P-
heterogeneity 
Any exertion 16 22 5.3 (2.7 – 10.6)  
Light or moderate exertion 14 22 4.9 (2.5 – 9.7)  
Vigorous exertion 2 22 23.2 (5.8 – 91.9)  
Aerobic fitness (peak VO2)     
Above median° 3 9 1.2 (0.4 – 4.2) 
0.0023 
Below median 9 9 17.5 (5.2 – 58.5) 
Sedentary behaviour*     
No 10 14 3.2 (1.3 – 7.6) 
0.0002 
Yes 6 8 52.8 (10.1 – 277) 
°Median peak VO2 = 18.2 mL/kg/min 
*Patients who reported no moderate to vigorous exertion in the past 6 months at initial 
assessment were classified as sedentary and patients who reported any moderate to vigorous 
exertion were deemed not sedentary  
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Figure 5-1. Time of day of symptomatic ventricular arrhythmia among 22 MOVE-
IT patients 
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Chapter 6  
6 Freedom from ventricular arrhythmia by aerobic fitness 
and sedentary behaviour 
6.1 Introduction 
Habitual physical activity is widely recommended for older adults to reduce the risk of 
chronic disease, premature mortality, functional limitations, and disability1. A higher risk 
of cardiovascular disease in particular has been related to physical inactivity2. Some 
studies have described an increased risk of ventricular arrhythmia among individuals with 
lower levels of fitness and sedentary behaviour, however, other studies have found no 
significant improvement in risk after exercise therapy.  
Ventricular arrhythmia can be monitored and immediately treated by an implantable 
cardioverter-defibrillator (ICD). An ICD may provide life-saving treatment through 
discharge of Anti-Tachycardia Pacing (ATP) or shock, but ICD therapy is associated with 
psychological distress and a reduced quality of life3.  
In this chapter, we assessed the impact of aerobic fitness and habitually sedentary 
behaviour on freedom from ventricular arrhythmia. We hypothesized that lower levels of 
aerobic fitness, measured by peak VO2, and sedentary behaviour would reduce freedom 
from ventricular arrhythmia. 
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6.2 Methods 
6.2.1 Study population  
The MOVE-IT study is a cohort of 97 consecutive ICD patients in the London Health 
Sciences Centre in London, Ontario, Canada from May 2008 to July 2012. Chapter three 
describes the recruitment, inclusion criteria, and exclusion criteria of this study 
population in detail. In this chapter, we analyze all patients in the cohort, including those 
who did not experience ICD therapy for ventricular arrhythmia over the follow-up period.  
6.2.2 Study design 
MOVE-IT was a single-centre prospective cohort study. Patients were enrolled at the 
time of ICD implant. Patients returned for device interrogation 2 weeks after implant and 
every 6 months thereafter, in accordance with standard clinical practice. Baseline 
information on exposure (e.g. aerobic fitness and sedentary behaviour) was collected 
during the first study visit after implant and outcome status (e.g. ventricular arrhythmia) 
was collected in every subsequent scheduled clinic visit and any unscheduled clinic visit 
as well.   
6.2.3 Physical exertion 
Patients reported their physical exertion habits at an initial study visit, previously 
described in Chapter 5. Patients who reported no moderate to vigorous exertion in the 
past 6 months were classified as sedentary and patients who reported any moderate to 
vigorous exertion were deemed not sedentary. 
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6.2.4 Cardiopulmonary exercise stress testing 
A modified Bruce protocol, described in Chapter 5, was conducted 2 weeks after ICD 
implant to measure peak VO2, a proxy for aerobic fitness.  
6.2.5 ATP or shock 
Interrogation of the ICD provides a summary of detected arrhythmias; date, time, 
duration, therapies, and rhythm prior to onset are stored in the device memory. 
Electrograms were also available for each episode. The treating electrophysiologist and 
lead investigator (LJG) reviewed all stored electrograms to confirm appropriateness of 
therapy and ventricular origin of arrhythmia.   
6.2.6 Statistical analysis  
We constructed Kaplan Meier curves that calculated freedom from symptomatic 
ventricular arrhythmia. We tested if time to ventricular arrhythmia was different between 
people below and above the median level of peak VO2 in this sample and between 
individuals who were and were not sedentary using the log-rank statistic. We plotted the 
log minus log of survival against the log of survival time between patients above and 
below median peak VO2 and between patients who were and were not sedentary to assess 
proportionality of the hazard of ventricular arrhythmia between strata. Analyses were 
performed using SAS 9.4 (SAS Institute, Cary, NC).  
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6.3 Results 
The characteristics of the 97 patients in the cohort are presented in table 6-1. The mean 
age of these study patients was 60.9 ± 8.7. The mean left ventricular ejection fraction was 
26.5%, ranging from 13-70%. 54 patients (56%) had a history of myocardial infarction, 
33 patients (34%) had diabetes mellitus, and 91 (94%) were on beta blocker medication. 
81 (84%) patients received primary prevention ICD, and 16 (16%) received ICD for 
secondary prevention. 42 (45%) patients reported sedentary behaviour.  
The median length of follow-up was 2.6 years. Twenty-two patients (20 men, 2 women) 
had symptomatic ventricular arrhythmia. Five (23%) were ventricular tachycardia, 12 
(54%) were fast ventricular tachycardia, and 5 (23%) were ventricular fibrillation. Seven 
(32%) events were terminated by ATP alone, 5 (23%) by shock alone, and 10 (45%) by 
shock after ATP. The mean peak VO2 was 18.7 ± 5.8 mL/kg/min for patients who had 
ventricular arrhythmia and 17.7 ± 5.3 mL/kg/min for patients who did not have an event 
over the follow up period. Eight (36%) patients were sedentary among those who had 
ventricular arrhythmia and 34 (45%) were sedentary among patients who did not have 
ventricular arrhythmia.  
There was no statistically significant difference in freedom from ventricular arrhythmia 
for patients below the median level of aerobic fitness compared to patients above the 
median level of fitness (Figure 6-1, p log-rank = 0.93). Also, there was no statistically 
significant difference in freedom from ventricular arrhythmia for patients who were 
sedentary compared to patients who were not sedentary (Figure 6-2, p log-rank = 0.83). 
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6.4 Discussion 
We found no statistically significant difference in freedom from ventricular arrhythmia 
between patients above and below the median level of aerobic fitness and between 
patients who were and were not sedentary. While we found no association between 
aerobic fitness and time-to-ventricular arrhythmia, Cale et al.4 reported a 13% lower 
hazard of ventricular arrhythmia associated with a one unit increase in peak VO2 in a 
univariate analysis of a prospective cohort of ICD patients. Self-reported sedentary 
behaviour was not associated with a statistically significantly different survival from 
ventricular arrhythmia in our study, but two studies have reported benefits in people with 
ICDs with higher levels of physical activity measured by the single-axis accelerometer 
permanently situated in the ICD. Conraads et al.4 found that increased levels of physical 
activity were associated with a reduced hazard of death or hospitalization from heart 
failure. Also, higher levels of physical activity at baseline and varying with time were 
associated with a lower risk of death before and after adjustment for demographic and 
device characteristics in a study of nearly 100 000 patients with ICD5. 
Elevated sympathetic drive reduces the threshold for ventricular fibrillation, thereby 
potentiating the risk of ventricular arrhythmia6. The impact of this effect is magnified in 
the presence of poor ejection fraction7, a risk factor common among all patients at risk of 
ventricular arrhythmia. Meta-analyses in patients with chronic heart failure show that 
habitual physical activity reduces baseline adrenergic tone8 and improves ejection 
fraction9. Physical activity can also improve vagal regulation10, which is blunted in 
patients with heart failure and enhanced in trained athletes11. Increases in vagal tone 
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reduce the threshold for ventricular fibrillation experimentally12, and are associated with 
reduced risk of ventricular arrhythmia in patients with ICD13. With these mechanisms in 
mind, it is possible that physical activity may reverse autonomic dysregulation induced 
by cardiovascular disease and improve the electrical stability of the heart.  
6.4.1 Strengths and limitations 
We assessed aerobic fitness using peak VO2 which is an objective measure obtained from 
the results of a cardiopulmonary exercise stress test. We also prospectively collected data 
on habitual physical exertion at the time of ICD implant. In this way, having or not 
having a ventricular arrhythmia did not influence a patient’s self-report of either 
sedentary or non-sedentary behaviour. As well, we recruited patients consecutively to 
reduce the potential of selecting patients based on specified characteristics apart from the 
inclusion and exclusion criteria.   
Our study was limited by its sample size, which further reduced in our analysis assessing 
the impact of aerobic fitness. We had few events of ventricular arrhythmia and we did not 
use multivariable Cox regression in our survival model due to non-proportional hazards 
between our exposure groups in both analyses (Appendix E and F). Age, sex, and 
ejection fraction are a few factors associated with risk of ventricular arrhythmia. If these 
covariates are also associated with aerobic fitness or sedentary behaviour, they are 
potential confounders. Adjustment for lifestyle and socio-demographic characteristics 
may be an important consideration in measuring the association between the risk of 
ventricular arrhythmia and aerobic fitness and sedentary behaviour.  Further, we 
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determined habitually sedentary behaviour from a self-reported questionnaire. Therefore, 
it is possible that sedentary behaviour may be over or underreported by some patients.   
6.4.2 Conclusion 
We found no evidence to suggest that there is a statistically significantly different 
freedom from ventricular arrhythmia between patients above and below the median level 
of aerobic fitness and between patients who were and were not sedentary in our study 
sample.  
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Table 6-1:  Baseline characteristics of 97 MOVE-IT patients, mean ± SD or n (%) 
 
 Full cohort 
  
n=97 
Age (years) 60.9 ± 8.7 
Male 
Female 
78 (80%) 
19 (20%) 
Ejection fraction (%)° 26.5 ± 9.2 
Blood pressure (mmHg) 
Systolic 
Diastolic 
 
113.7 ± 17.4 
69.9 ± 10.2 
Body mass index (kg/m2) 29.5 ± 4.8 
Peak VO2 (mL/kg/min)
* 18.0 ± 5.4 
Sedentary† 42 (45%) 
QRS length (ms) 137.0 ± 30.5 
Cardiovascular history—n (%)  
 Ischemic heart disease 52 (54%) 
 Bypass 20 (21%) 
 Percutaneous coronary intervention 
Myocardial infarction 
Non-Ischemic cardiomyopathy 
Congestive heart failure 
Valvular heart surgery 
Congenital heart surgery 
Peripheral vascular disease 
16 (17%) 
54 (56%) 
36 (37%) 
73 (75%) 
4 (4%) 
1 (1%) 
2 (2%) 
Indication for ICD  
 Primary Prevention 81 (84%) 
 Secondary Prevention 16 (16%) 
Other Medical history—n (%)  
 Diabetes mellitus 33 (34%) 
 Hypertension 
Hyperlipidemia 
Thyroid disease 
Chronic obstructive pulmonary disease 
45 (47%) 
40 (41%) 
2 (2%) 
13 (13%) 
Cardiac medication history—n (%)  
 Beta blocker 91 (94%) 
 ACE inhibitors 
Angiotensin receptor blocker 
Diuretic 
Digoxin 
80 (82%) 
16 (17%) 
68 (70%) 
26 (27%) 
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 Full cohort 
Calcium channel blocker 
Class 1 antiarrhythmic 
Warfarin 
3 (3%) 
9 (9%) 
13 (13%) 
°13 patients did not have information on ejection fraction 
*Patients who reported no moderate to vigorous exertion in the past 6 months at initial 
assessment were classified as sedentary and patients who reported any moderate to vigorous 
exertion were deemed not sedentary 
†30 (31%) patients did not provide consent to undergo exercise stress testing. The mean age of 
patients who did not provide consent was lower than those who provided consent (58.3 vs 62.0, 
p=0.05). There was a higher proportion of sedentary patients among those who did not provide 
consent (56%) than among those who did provide consent (40%, p=0.18). 
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Figure 6-1. Freedom from ventricular arrhythmia among 67 MOVE-IT patients 
stratified by aerobic fitness above and below the sample median 
 
 
Median aerobic fitness measured by peak VO2 = 18.0 mL/kg/min  
Log-rank test p = 0.93 
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Figure 6-2. Freedom from ventricular arrhythmia among 94 MOVE-IT patients 
stratified by sedentary behaviour 
 
 
Patients who reported no moderate to vigorous exertion in the past 6 months at initial assessment 
were classified as sedentary and patients who reported any moderate to vigorous exertion were 
deemed not sedentary  
Log-rank test p = 0.83 
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Chapter 7  
7 Discussion and implications 
In Chapter 5, we examined the immediate risk of ventricular arrhythmia following an 
episode of exertion. In our clinical population, we found that the risk of ventricular 
arrhythmia was higher within an hour of exertion compared to periods of rest, and that 
this association was stronger among patients with lower levels of aerobic fitness and 
among patients who were sedentary. In Chapter 6, we assessed the baseline risk of 
incident ventricular arrhythmia over the follow-up period and found no statistically 
significant difference in freedom from ventricular arrhythmia by level of aerobic fitness 
or sedentary behaviour in our sample. In contrast, several larger observational studies 
have found a higher risk of ventricular arrhythmia and cardiovascular events among 
individuals with lower levels of aerobic fitness and among those with lower levels of 
habitual physical exertion. 
Our finding that there is an elevated risk of ventricular arrhythmia in the hour following 
physical exertion is consistent with the two prior case-crossover studies that examined 
this question in the ICD population. Lampert et al. reported a 3.87 (95% CI 1.97 – 14.8) 
times greater odds of ICD shock up to 15 minutes following self-reported mild-to-
moderate physical activity compared to other times1. Fries et al. found similar results, 
reporting the relative risk of ICD shock as 7.5 (95% CI 5.2 – 11.1) times greater within 1 
hour after physical stress compared to periods of rest2. Moreover, our finding that the 
immediate risk of ventricular arrhythmia following physical exertion is greater in people 
who are sedentary is consistent with previous studies that found that among people who 
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are sedentary, there is a higher immediate risk of myocardial infarction and sudden 
cardiac death following physical exertion. This is the first study to show that sedentary 
behaviour also elevates the immediate risk of ventricular arrhythmia following exertion, 
as do lower levels of aerobic fitness.  
Based on our findings that the immediate risk of ventricular arrhythmia is lower among 
patients with relatively higher levels of aerobic fitness and those who are not sedentary, it 
is possible that an exercise regimen with an incremental increase in the intensity of 
exertion may help to minimize the risk of ventricular arrhythmias associated with isolated 
episodes of physical exertion by improving aerobic fitness. These improvements can be 
achieved among patients with ICDs. In a randomized controlled trial (RCT) of 52 men 
with chronic heart failure who had ICDs, exercise training improved aerobic fitness and 
quality of life within 8 weeks3. In a post-hoc analysis of over 1000 patients with heart 
failure and ICDs enrolled in an RCT, Piccini et al. found that randomizing sedentary 
individuals to exercise 3 times a week was not associated with the combined endpoint of 
appropriate and inappropriate shocks and all-cause mortality4. By increasing the 
frequency of exertion, the time at risk of exertion-induced ventricular arrhythmia would 
be higher in the intervention group compared to the control group. Therefore, the fact that 
there was no difference in risk of ventricular arrhythmia between the two groups may 
suggest that the exertion improved fitness and thereby lowered the risk of exertion-
induced ventricular arrhythmias. In Chapter 6, we did not find a statistically significant 
difference in survival from ventricular arrhythmia by level of fitness or sedentary 
behaviour, but several larger observational studies have reported a higher baseline risk of 
ventricular arrhythmia and cardiovascular events associated with lower levels of fitness 
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and sedentary behaviour. Even habitual activity at low levels of intensity is associated 
with a lower baseline risk of cardiovascular events5-7, and it is possible that it also lowers 
the risk of ventricular arrhythmia from each episode of exertion. 
7.1 Strengths and limitations 
In Chapter 5, our study found that effect modification of the immediate risk of ventricular 
arrhythmia following physical exertion was robust across two independently collected 
measures. While sedentary behaviour is a self-reported and subjective measure whose 
interaction with the immediate risk of myocardial infarction and stroke has been studied 
before, we also demonstrated a similar increase in the immediate risk of ventricular 
arrhythmia among individuals with lower levels of aerobic fitness, an objectively 
collected metric.  
This study was also strengthened through prospective measurement of baseline habitual 
physical exertion that was completed during the initial study visit. In this way, the 
occurrence of ventricular arrhythmia over follow-up could not influence a patient’s 
perspective of their self-reported participation in physical exertion. This study was 
however limited by the subjective and self-reported nature of the baseline physical 
exertion measurements. While patients were provided with a visual analogue scale to 
gauge intensity and given examples of common activities among older adults that would 
help capture all habitual physical exertion (e.g. gardening, yard work), it is not known 
how accurately these estimates reflect true participation in physical exertion in our 
population. Self-report was also used to classify exposure to physical exertion in the hour 
preceding ventricular arrhythmia, but because our interviews occurred within 72 hours of 
ICD discharge, it is likely that patients more accurately remember their level of exposure 
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to physical exertion at the time of their first device-treated ventricular arrhythmia. It is 
important to note that while the ICD has an activity sensor which records whether or not 
a patient is “active” at the time of ventricular arrhythmia, it does not measure activity at 
any other moment in the hour before therapy. The ICD activity sensor is therefore limited 
in our purpose since the hazard period of transiently elevated risk lasts longer than an 
episode of exertion itself8, notably because recovery from exertion is impaired in patients 
with poor heart function9 and benign ventricular arrhythmia during recovery is actually a 
stronger predictor of mortality than benign ventricular arrhythmia during exertion11.  
The case-crossover study design is self-matched and therefore eliminates confounding by 
fixed and slow-varying characteristics during the study period, such as age, sex, and 
comorbidities. Further, because exposure to physical exertion at baseline and 
immediately preceding the event were classified by the patient, it is likely that their 
perception of light, moderate, and vigorous exertion are consistent between these two 
compared time periods. While self-matched analysis eliminates the issue of non-
exchangeability between persons, confounding within each person remains a possibility. 
If physical exertion is associated with another potential trigger of ventricular arrhythmia 
(e.g. sex, caffeine, time of day, stress) then it is possible that the association between 
exertion and ventricular arrhythmia is confounded by the co-exposure. In the MOVE-IT 
study, patients completed a semi-structured questionnaire after ICD discharge where they 
briefly described the minutes preceding ventricular arrhythmia (Appendix B), but it is 
possible that some co-exposures to physical exertion were intentionally or unintentionally 
omitted.  
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7.2 Conclusion and future directions 
In this clinical population, there is an elevated risk of ventricular arrhythmia within an 
hour of physical exertion, especially among individuals with lower levels of aerobic 
fitness and with sedentary behaviour. Prior studies indicate that lower levels of aerobic 
fitness and habitually sedentary behaviour increase the baseline risk of ventricular 
arrhythmia and cardiovascular events. Future research is therefore necessary to design 
and evaluate activity recommendations that maximize the benefits of habitual activity and 
exercise training while minimizing the risk of ventricular arrhythmia associated with each 
episode of exertion.  
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Appendix A: MOVE-IT Baseline Survey 
 
PHYSICAL ACTIVITY 
 
LIGHT EXERTION 
 
Since implantation, or in the past 6 months, on average how often do you participate in: 
 
Light exertion physical activities, with normal breathing (corresponding to # 4 on the visual analog scale): 
Time(s): ____ per    day 
    week 
    month 
    year 
 
What is the usual duration of each episode of activity at this level? _____      hour(s)    minutes 
 
The following question concerns the usual time of the day that you perform light exertion physical activities. 
What percent of your light exertion activities occurs in the following time intervals? 
(the total percentages should sum to 100%) 
 
 6 AM - Noon ___%      Noon – 6 PM ___%      6 PM – Midnight ___%      Midnight – 6 AM ___% 
 
What activity do you usually engage in at this level?___________________________________ 
 
MODERATE EXERTION 
 
Since implantation, or in the past 6 months, on average how often do you participate in: 
 
Moderate exertion physical activities, with deep breathing (corresponding to # 5 on the scale):   
Time(s): ____ per  day 
               week 
               month 
               year 
 
What is the usual duration of each episode of activity at this level? _____      hour(s)    minutes 
 
The following question concerns the usual time of the day that you perform moderate exertion                            
physical activity. What percent of your moderate exertion physical activities occurs in the following intervals?  
(the total percentages should sum to 100%) 
 6 AM –Noon ___%       Noon –6PM ___%       6 PM- Midnight ___%       Midnight – 6AM ___% 
 
What activity do you usually engage in at this level? 
 
VIGOROUS EXERTION 
 
Since implantation, or in the past 6 months, on average how often do you participate in: 
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Vigorous exertion physical activities, with panting; overheating (corresponding to #6 on the visual analog 
scale): 
Time(s): ____ per  day 
    week  
    month 
    year 
What is the usual duration of each episode of activity at this level? _____      hour(s)    minutes 
 
The following question concerns the usual time of the day that you perform vigorous exertion                            
physical activity. What percent of your vigorous exertion physical activities occurs in the following intervals?   
(the total percentages should sum to 100%) 
 6 AM –Noon ___%       Noon –6PM ___%       6 PM- Midnight ___%       Midnight – 6AM ___% 
 
What activity do you usually engage in at this level? __________________________________ 
 
WALKING AND CLIMBING 
 
Since implantation, or in the past 6 months: 
 
1. How many city blocks do you walk each day? _____ 
(assuming 1 km = 6 blocks) 
 
2. What is your usual pace of walking?  casual strolling  
                average or normal 
                fairly brisk 
                striding 
 
3. How many flights of stairs do you climb up each day? _____ 
(assuming 10 steps = 1 flight) 
 
 
SEX    
How often do you have sexual intercourse?  
____times per 
never 
day 
week 
month 
year 
 
The following question concerns the usual time of day that you have sexual intercource ercourse   
What percent of your sexual intercourse 
occurs in the following intervals? 
6 a.m.-Noon      ___% 
Noon-6 p.m.       ___% 
6 p.m.-Midnight  ___% 
Midnight-6 a.m.  ___% 
  
 
 
 56 
 
Appendix B: MOVE-IT Post-therapy form 
MOVE-IT PAPER FORMS 
Post-ICD (Shock) Follow-up 
 
POST ICD DISCHARGE 
 
(Completed within 72 hours of ICD discharge, either via telephone or during clinic visit. If during clinic visit, please 
fill out follow-up clinic data form at the same time) 
 
Please obtain the following information from the patient as soon as possible after a device discharge. 
Encourage the patient to give his or her best answer to each question.  
 
Mean ICD-recorded heart rate over 30 seconds prior to ICD therapy: _______bpm 
 
DAY OF DISCHARGE 
 
10. What time did you get up on the day of device discharge? ______  AM   PM 
 
11. What were you doing when the discharge occurred?   no specific activity 
           lying 
           sitting 
           standing 
           walking  
           running 
           climbing stairs 
 
12. Please write out the specific activity you were engaged in at the time of the shock: 
_______________________________ 
 
13. Please briefly describe the minutes immediately following the shock: 
 
 
 
 
 
14. Were you having any symptoms before the device discharge?   Yes  No 
 
  Symptoms before the discharge( please fill all that apply): 
 
Symptom Duration How long before device discharge? 
Chest pain, discomfort, angina 
Dizziness 
Nausea or vomiting 
Palpitations 
Shortness of breath 
Syncope 
Other(specify) 
 Less than ½ hour                                    
Between ½ and 1 hour                            
Between 1 and 2 hours                           
Greater than 2 hours                               
More than 2 hours but less than 2 days  
Other                                                       
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Chest pain, discomfort, angina 
Dizziness 
Nausea or vomiting 
Palpitations 
Shortness of breath 
Syncope 
Other(specify) 
 Less than ½ hour                                    
Between ½ and 1 hour                            
Between 1 and 2 hours                           
Greater than 2 hours                               
More than 2 hours but less than 2 days  
Other                                                       
Chest pain, discomfort, angina 
Dizziness 
Nausea or vomiting 
Palpitations 
Shortness of breath 
Syncope 
Other(specify) 
 Less than ½ hour                                    
Between ½ and 1 hour                            
Between 1 and 2 hours                           
Greater than 2 hours                               
More than 2 hours but less than 2 days  
Other                                                       
15. Did your symptoms go away after the shock?   Yes   No 
 
16. Did you have any symptoms after the discharge?  Yes   No 
 
 
BEHAVIORAL PRECURSORS  
 
Before the device discharge, when was the last time you were engaged in: 
  Please select the closest option: 
 
Light exertion with normal breathing 
 (E.g.: mopping, normal walking (shopping), golfing with a car, sweeping, gardening with power tools) 
  Never/Not applicable 
  At the time of shock 
  ½ hour before 
  1 hour before 
  2 hours before 
  3-6 hours before 
  6-24 hours before 
  1-2 days before 
  3-4 days before 
  5 or more days before 
 
Moderate exertion with deep breathing 
 (E.g.: brisk walking, golfing on foot, ballroom dancing, slow dancing, slow biking, downhill skiing, cleaning windows, 
hanging wallpaper, interior painting, light restaurant work (like waiting tables)) 
  Never/Not applicable 
  At the time of shock 
  ½ hour before 
  1 hour before 
  2 hours before 
  3-6 hours before 
  6-24 hours before 
  1-2 days before 
  3-4 days before 
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  5 or more days before 
 
Vigorous exertion, panting/overheating, or exertion with gasping and much sweating: 
 (E.g.: sprinting, running, jogging, fast bicycling, football, mixing cement, hanging drywall, using jackhammer, speed 
walking, tennis, swimming, shoveling, pruning trees, heavy gardening, brick laying) 
  Never/Not applicable 
  At the time of shock 
  ½ hour before 
  1 hour before 
  2 hours before 
  3-6 hours before 
  6-24 hours before 
  1-2 days before 
  3-4 days before 
  5 or more days before 
 
 
Sexual intercourse 
 Never/Not applicable 
  At the time of shock 
  ½ hour before 
  1 hour before 
  2 hours before 
  3-6 hours before 
  6-24 hours before 
  1-2 days before 
  3-4 days before 
  5 or more days before 
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Appendix C: Adapted Borg Visual Analog Scale used by MOVE-IT patients to report intensity of 
physical exertion 
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Appendix D: Case-crossover comparison schematic 
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Appendix E: Log minus log plot of the hazard of ventricular arrhythmia between individuals 
above and below the median aerobic fitness in 67 MOVE-IT patients 
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Appendix F: Log minus log plot of the hazard of ventricular arrhythmia between individuals who 
were and were not sedentary among 94 MOVE-IT patients 
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